D.E. Shaw & Co
VIE

D.E. Shaw & Co’s Viela Bio, Inc. Common Stock VIE Stock Holding History

D.E. Shaw & Co’s Portfolio VIE Stock Details VIE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-29,638
Closed -$805K – 4411
2019
Q4 		$805K Buy
+29,638
New +$747K ﹤0.01% 3126

Other funds holding VIE

HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

D.E. Shaw & Co's VIE Position: Q1 2020 in Review

D.E. Shaw & Co sold out of Viela Bio, Inc. Common Stock (VIE) in Q1 2020, closing a stake of 29,638 shares — an estimated $805K sold.

D.E. Shaw & Co first reported a position in VIE in Q4 2019 and held it in 1 quarter. The position peaked at $805K in Q4 2019. 47 funds tracked by Wall St. Rank hold VIE as of Q1 2020.

  • D.E. Shaw & Co reported no remaining Viela Bio, Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
  • D.E. Shaw & Co sold 29,638 Viela Bio, Inc. Common Stock shares in Q1 2020, an estimated $805K.
  • D.E. Shaw & Co first reported a position in Viela Bio, Inc. Common Stock in Q4 2019 and held it in 1 quarter.
  • D.E. Shaw & Co's Viela Bio, Inc. Common Stock position peaked at $805K in Q4 2019.
  • 47 funds tracked by Wall St. Rank held Viela Bio, Inc. Common Stock as of Q1 2020.

Based on D.E. Shaw & Co's 13F filing for Q1 2020, filed 15 May 2020.